A 📈 Agilent Technologies - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016

A: Spectrometers, Chromatographs, Analyzers, Instruments, Software, Automation

Agilent Technologies, Inc. is a global leader in providing application-focused solutions to the life sciences, diagnostics, and applied chemical markets. The company's extensive portfolio of products and services is designed to cater to the diverse needs of these industries, enabling customers to achieve their goals more efficiently. With a strong presence in over 100 countries, Agilent Technologies, Inc. has established itself as a trusted partner for companies and organizations seeking to advance their research, development, and manufacturing capabilities.

The company operates through three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers a broad range of products, including liquid chromatography systems, mass spectrometry systems, gas chromatography systems, and inductively coupled plasma mass spectrometry instruments. Additionally, this segment provides cell analysis plate-based assays, flow cytometers, real-time cell analyzers, and cell imaging systems, among other products. These solutions enable customers to analyze and understand complex biological systems, driving advancements in fields such as pharmaceuticals, biotechnology, and environmental monitoring.

The Diagnostics and Genomics segment is focused on the development and commercialization of innovative solutions for genomics, nucleic acid contract manufacturing, and biomolecular analysis. This segment also provides products and services for pathology, companion diagnostics, and research and development, supporting the discovery of new biomarkers and the development of personalized medicines. By leveraging its expertise in genomics and diagnostics, Agilent Technologies, Inc. is helping to transform the field of healthcare, enabling earlier disease detection, more accurate diagnosis, and more effective treatment.

The Agilent CrossLab segment offers a comprehensive range of products and services designed to support laboratory operations, including GC and LC columns, sample preparation products, and custom chemistries. This segment also provides a suite of services, including repairs, maintenance, installations, training, and compliance support, to help customers optimize their laboratory workflows and ensure regulatory compliance. Furthermore, Agilent CrossLab offers software as a service, asset management, and consulting services, enabling customers to streamline their operations, reduce costs, and improve productivity.

Agilent Technologies, Inc. markets its products and services through a multi-channel approach, utilizing direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. This flexible approach enables the company to reach a broad range of customers, from small research institutions to large pharmaceutical companies, and provide them with the solutions they need to achieve their goals. With a strong commitment to innovation, quality, and customer satisfaction, Agilent Technologies, Inc. has established itself as a leader in the life sciences tools and services industry, with a global presence and a reputation for excellence.

Founded in 1999 and headquartered in Santa Clara, California, Agilent Technologies, Inc. is a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol A. The company's common stock is traded under the ISIN code US00846U1016, and it is classified under the GICS Sub Industry: Life Sciences Tools & Services. With a rich history of innovation and a strong track record of growth, Agilent Technologies, Inc. is well-positioned to continue driving advancements in the life sciences, diagnostics, and applied chemical markets, and to deliver value to its customers, shareholders, and stakeholders.

Additional Sources for A Stock

A Stock Overview

Market Cap in USD 41,068m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 1999-11-18

A Stock Ratings

Growth 5y 37.3%
Fundamental 69.3%
Dividend 46.8%
Rel. Strength Industry -139
Analysts 3.7/5
Fair Price Momentum 122.51 USD
Fair Price DCF 124.55 USD

A Dividends

Dividend Yield 12m 0.70%
Yield on Cost 5y 1.15%
Annual Growth 5y 6.27%
Payout Consistency 65.2%

A Growth Ratios

Growth Correlation 3m -41.1%
Growth Correlation 12m 9.8%
Growth Correlation 5y 47.9%
CAGR 5y 10.29%
CAGR/Mean DD 5y 0.61
Sharpe Ratio 12m -0.16
Alpha -27.53
Beta 0.93
Volatility 26.83%
Current Volume 4363.9k
Average Volume 20d 2022.1k
What is the price of A stocks?
As of December 21, 2024, the stock is trading at USD 134.51 with a total of 4,363,900 shares traded.
Over the past week, the price has changed by -3.23%, over one month by +4.62%, over three months by -3.83% and over the past year by -2.00%.
Is Agilent Technologies a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Agilent Technologies (NYSE:A) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 69.31 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of A as of December 2024 is 122.51. This means that A is currently overvalued and has a potential downside of -8.92%.
Is A a buy, sell or hold?
Agilent Technologies has received a consensus analysts rating of 3.70. Therefor, it is recommend to hold A.
  • Strong Buy: 6
  • Buy: 3
  • Hold: 10
  • Sell: 1
  • Strong Sell: 0
What are the forecast for A stock price target?
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 135.4 in December 2025. The stock is currently trading at 134.51. This means that the stock has a potential upside of +0.64%.
Issuer Forecast Upside
Wallstreet Target Price 148.6 10.5%
Analysts Target Price 135.8 0.9%
ValueRay Target Price 135.4 0.6%